Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of melanin-pigmented dendritic cells.
Biomarker and diagnostic research for pigmented dermatofibrosarcoma protuberans has been reported in the published literature.
No clinical trials have been registered for pigmented dermatofibrosarcoma protuberans.
7 publications have been identified in PubMed for pigmented dermatofibrosarcoma protuberans. Research spans Case Report / Case Series (57%), Other (14%), and Diagnostic / Biomarker (14%).
Chen Y (2026). [PMID: 41907602](https://pubmed.ncbi.nlm.nih.gov/41907602/). *Front Oncol*. [Case Report / Case Series]
Neyaz A (2026). [PMID: 41025914](https://pubmed.ncbi.nlm.nih.gov/41025914/). *Histopathology*. [Diagnostic / Biomarker]
Alcocer Salas M (2026). [PMID: 41798509](https://pubmed.ncbi.nlm.nih.gov/41798509/). *Cureus*. [Case Report / Case Series]
Zhong S (2025). [PMID: 40357944](https://pubmed.ncbi.nlm.nih.gov/40357944/). *Indian J Dermatol Venereol Leprol*. [Other]
Cazzato G (2025). [PMID: 40172048](https://pubmed.ncbi.nlm.nih.gov/40172048/). *Am J Dermatopathol*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:43 AM UTC
Zhang Y (2024). [PMID: 39634408](https://pubmed.ncbi.nlm.nih.gov/39634408/). *Heliyon*. [Case Report / Case Series]
AI-curated news mentioning pigmented dermatofibrosarcoma protuberans
Updated Apr 6, 2026
A case report details a rare instance of primary synovial sarcoma of the breast that initially presented as dermatofibrosarcoma protuberans. This finding contributes to the understanding of differential diagnoses in rare breast tumors.